Use of Misoprostol in Hysteroscopic Myomectomy
ConditionHysteroscopic Myomectomy
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age20-55
SponsorAssuta Ashdod Hospital
About this trial
Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.
Eligibility criteria
Qualifiers
women between the ags of 20 years- 55 years, inclusive
undergoing hysteroscopic myomectomy
submucosal fibroid less than 40 mm (type 0, 1 and 2)
up to 2 submucosal fibroids
Disqualifiers
post menopausal women
inability to perform operative hysteroscopy under anesthesia in the past due to cervical stenosis
previous PID or documented tubal occlusion
positive BHCG test
Trial design
Treatments tested in this trial
- Misoprostol 400 Microgram Oral Tablet
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Assuta Ashdod Hospital
Lead sponsor
Assuta Medical Center
Collaborator
Source ClinicalTrials.gov